Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2024 Dec;45(12):1355-1367.
doi: 10.15537/smj.2024.45.12.20240796.

Differentiating mycosis fungoides lesions from their mimickers clinically and histologically: A single tertiary center retrospective analysis in Saudi Arabia

Affiliations
Observational Study

Differentiating mycosis fungoides lesions from their mimickers clinically and histologically: A single tertiary center retrospective analysis in Saudi Arabia

Fatimah M Budair et al. Saudi Med J. 2024 Dec.

Abstract

Objectives: To identify the clinical and histological features of MF that can assist in distinguishing MF from MF-mimicking cases. Although mycosis fungoides (MF) is the most common subtype of cutaneous T-cell lymphoma, clinicopathological correlations are required to establish an accurate diagnosis, which are currently lacking.

Methods: This retrospective observational study evaluated the clinical presentations, characteristics, and histological features of 56 patients with suspected MF who presented to our clinic between January 2018 and August 2022. Immunohistochemistry was performed, and the loss of CD5 and CD7 T-cells and T-cell receptor rearrangement was evaluated.

Results: Overall, 34 patients were diagnosed with MF, whereas 22 were not. Clinical erythroderma, poikiloderma, and nodular presentations were more commonly associated with a histological diagnosis of MF than macular presentations. Erythema and pruritus were significantly more common in MF cases than in MF-mimicking cases (p<0.05). Epidermotropism and parakeratosis were the key histological features for diagnosing MF. Additionally, Pautrier's microabscesses correlated with the clinical presentation of plaques in MF. Loss of CD7 expression on the T-cell surface was observed even in early-stage MF cases.

Conclusion: Our proposed diagnostic features are statistically valid and, along with those previously reported, can aid in identifying and distinguishing MF cases from MF-mimicking cases.

Keywords: dermatology; histopathology; immunohistochemistry; mycosis fungoides.

PubMed Disclaimer

Figures

Figure 1
Figure 1
- Clinical presentations and characteristics of lesions suspicious of MF. (A) Patches present for > 6 months in the upper arm and trunk that were associated with hypopigmentation; the lesions were suspicious of MF. (B) Multiple erythematous papules, accompanied by intense pruritus of the upper arms and H&E-confirmed MF diagnosis. (C) Multiple hyperpigmented scaly patches involving the trunk and H&E-confirmed MF diagnosis. (D) Clinical characteristics of lesions suspicious of MF and their presence in MF cases (n=34) and non-MF cases (n=22). The graph shows that erythema and itching were significantly more common in MF cases than in non-MF cases. H&E: hematoxylin and eosin staining, MF: mycosis fungoides
Figure 2
Figure 2
- Histological features used in the study to distinguish mycosis fungoides (MF) from non-MF cases. A) Epidermotropism is significantly found in MF cases compared with non-MF cases. B) Spongiosis (Grade 1) is present in MF cases, where it is located at the epidermal sites invaded by atypical lymphocytes (black rectangle). Areas not invaded by atypical lymphocytes show no spongiosis (black arrow). C) Pautrier’s microabscesses are significantly found more in the plaque stage than in the patch stage of MF (original, ´200 all).
Figure 3
Figure 3
- Immunohistochemical staining of mycosis fungoides cases. A) Positive expression of pan T-cell markers (CD3). B) Positive expression of CD4. C) Positive expression of CD8 with a ratio of 2.5:1 epidermally. D) Positive expression of CD5. (E) Loss of CD7. (original, ´200 all)

Similar articles

References

    1. Hossain C, Jennings T, Duffy R, Knoblauch K, Gochoco A, Chervoneva I, et al. . The histological prevalence and clinical implications of folliculotropism and syringotropism in mycosis fungoides. Chin Clin Oncol 2019; 8: 6. - PubMed
    1. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. . WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768–3785. - PubMed
    1. Wilcox RA. Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management. Am J Hematol 2017; 92: 1085–1102. - PubMed
    1. Quaglino P, Pimpinelli N, Berti E, Calzavara-Pinton P, Alfonso Lombardo G, Rupoli S, et al. . Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas. Cancer 2012; 118: 5830–5839. - PubMed
    1. Pimpinelli N, Olsen EA, Santucci M, Vonderheid E, Haeffner AC, Stevens S, et al. . Defining early mycosis fungoides. J Am Acad Dermatol 2005; 53: 1053–1063. - PubMed

Publication types

LinkOut - more resources